Dr. Hae Young Aaron Song, MD

Dr. Song practices at Allergy Associates of Orange County, Inc. in Yorba Linda, California.

Dr. Song's NPI, 1831181569, was assigned on August 18, 2005. Dr. Song graduated from University Of Washington School Of Medicine in 1997. Dr. Song holds California license A068359.

Dr. Song's primary practice is Allergy Associates of Orange County, Inc., at 16960 Bastanchury Rd, Yorba Linda, CA 92886 in Orange County. The practice phone is (714) 777-8845.

Dr. Song's primary practice is Allergy Associates of Orange County, Inc. in Yorba Linda, California. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Dr. Song to 1 more physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Song practices. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Song's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Song is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dr. Song is licensed in California.

Dmand AI lists asthma, chronic nasal allergies, hives and immune deficiency disease among the conditions Dr. Song treats.

CMS data shows 1,189 Medicare services from Dr. Song across 6 procedure codes in 2024, for 84 Medicare patients. Medicare paid $17,941 for them. Every service was in an office.

CMS counts 84 Medicare patients who saw Dr. Song in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have high cholesterol, and 63% have high blood pressure. Their average risk score is 0.90, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Song's median patient age at 32, with 55% women.

In 2024, Dr. Song wrote 316 Medicare Part D claims for 64 patients. 53% of them were for generic drugs. CMS names the drug for 241 of them, across 13 drugs with 11 or more claims each, at $86,382 in total drug cost. In 2023, CMS named 262 claims across 12 drugs.

Dr. Song accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Song in 2020. Dr. Song's most frequent co-authors are Brian Shigenobu Furukawa, MD and Laren Dao-Wei Tan, MD.

CMS Open Payments shows 414 general payments to Dr. Song from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 49% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $8,574.

Dr. Song graduated from University Of Washington School Of Medicine in 1997.

Dr. Song is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.